Clinical Trials
7
Active:0
Completed:6
Trial Phases
3 Phases
Phase 1:2
Phase 2:3
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (42.9%)Phase 1
2 (28.6%)Phase 4
2 (28.6%)Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
Phase 4
- Conditions
- Actinic Keratosis
- First Posted Date
- 2012-08-02
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 50
- Registration Number
- NCT01656226
- Locations
- 🇮🇹
Dermatology Unit, Medical Department Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal
Phase 2
Completed
- Conditions
- Local Anesthesia
- Interventions
- Drug: Lambdalina® (Lidocaine 4% cream)Drug: Placebo
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 42
- Registration Number
- NCT01360749
- Locations
- 🇪🇸
Clínica Dermatológica Campo De Felipe, Barcelona, Spain
🇪🇸Clínica Dermatológica Láser, Madrid, Spain
Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study
- First Posted Date
- 2008-10-28
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 38
- Registration Number
- NCT00781053
- Locations
- 🇩🇪
Herz- und Rheumazentrum Kerckhoff-Klinik, Bad Hauheim, Germany
🇩🇪Allergie-Centrum-Charité, Abteilung für, Berlin, Germany
🇩🇪Klinikum der Johan Wolfgang Goethe-Universitat, Frankfurt, Germany
Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2008-11-05
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 36
- Registration Number
- NCT00656825
- Locations
- 🇪🇸
Hospital Universitario Puerta de Hierro, Madrid, Spain
🇪🇸Clínica Universitaria de Navarra, Pamplona, Spain
Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test
Phase 1
Completed
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2008-11-05
- Lead Sponsor
- ISDIN
- Target Recruit Count
- 25
- Registration Number
- NCT00578370
- Locations
- 🇩🇪
Bioskin, Hamburg, Germany
- Prev
- 1
- 2
- Next
News
No news found